Reference number : 236-2012-2013-Q2-00141, amendment number : , agreement type : G, recipient legal name : JAMES, Michael N, recipient country : CA, recipient province : AB, recipient city : Edmonton, recipient postal code : T6G 2E1, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 387633.0, agreement start date : 2012-10-01, agreement end date : 2015-09-30, description english : Mucopolysaccharidosis I Disease:  Tools for Discovery and Design of Chaperone Therapeutics Based on Unique Enzyme Production Systems and the Elucidation of the Structure of alpha-L-Iduronidase, description french : Mucopolysaccharidosis I Disease:  Tools for Discovery and Design of Chaperone Therapeutics Based on Unique Enzyme Production Systems and the Elucidation of the Structure of alpha-L-Iduronidase, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2012-13 to 2015-16), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2012-13 à 2015-16), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada